{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:29:58Z","timestamp":1790764198976,"version":"4.1.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T00:00:00Z","timestamp":1578700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Platelet-transfusion refractoriness (PTR) is common in patients with hematological malignancies. The etiology of immune PTR is typically human leukocyte antigen (HLA) antibodies (Abs) from pregnancy or previous transfusion. Herein, we report PTR in the setting of induction chemotherapy for acute myelogenous leukemia (AML) from Abs against CD36\/glycoprotein (GP)IV. A 66-year-old African American woman presented with anemia and thrombocytopenia. She was found to have transfusion-dependent AML, and a 7 + 3 regimen (7 days of standard-dose cytarabine and 3 days of an anthracycline antibiotic or an anthracenedione, most often daunorubicin) was initiated. The patient developed profound thrombocytopenia, with platelet nadir of 0 by day 13. The results of HLA antibody screening were negative. However, the results of a screening test for platelet-specific antibodies screen showed Abs against cluster of differentiation (CD)36. The platelets of the patient lacked expression of CD36, and DNA analysis showed mutations in the CD36 gene. HLA Ab\u2013mediated PTR is common in patients with hematological malignancies. However, once HLA Abs are excluded, other less-frequent Abs should be considered, particularly in patient populations of Asian, African, or Middle Eastern descent.<\/jats:p>","DOI":"10.1093\/labmed\/lmz091","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T20:10:51Z","timestamp":1576008651000},"page":"540-544","source":"Crossref","is-referenced-by-count":11,"title":["Severe Platelet Transfusion Refractoriness in Association with Antibodies Against CD36"],"prefix":"10.1093","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9073-3173","authenticated-orcid":false,"given":"Amy E","family":"Schmidt","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanmay","family":"Sahai","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York"},{"name":"Department of Hematology and Oncology, Lenox Hill Hospital, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majed A","family":"Refaai","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Sullivan","sequence":"additional","affiliation":[{"name":"The Platelet & Neutrophil Immunology Laboratory, Blood Center of Wisconsin (part of Versiti), Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R","family":"Curtis","sequence":"additional","affiliation":[{"name":"The Platelet & Neutrophil Immunology Laboratory, Blood Center of Wisconsin (part of Versiti), Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,1,11]]},"reference":[{"issue":"3","key":"2020090103123049000_CIT0001","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2008.07189.x","article-title":"Platelet transfusion refractoriness","volume":"142","author":"Hod","year":"2008","journal-title":"Br J Haematol."},{"issue":"10","key":"2020090103123049000_CIT0002","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood."},{"issue":"2","key":"2020090103123049000_CIT0003","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.transci.2014.02.014","article-title":"Molecular typing of human platelet and neutrophil antigens (HPA and HNA)","volume":"50","author":"Veldhuisen","year":"2014","journal-title":"Transfus Apher Sci."},{"issue":"4","key":"2020090103123049000_CIT0004","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1537-2995.1996.36496226147.x","article-title":"Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians","volume":"36","author":"Curtis","year":"1996","journal-title":"Transfusion."},{"issue":"12","key":"2020090103123049000_CIT0005","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1111\/j.1537-2995.2010.02749.x","article-title":"Two cases of platelet transfusion refractoriness associated with anti-CD36","volume":"50","author":"Saw","year":"2010","journal-title":"Transfusion."},{"issue":"7","key":"2020090103123049000_CIT0006","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/trf.14122","article-title":"Detection and identification of platelet antibodies using a sensitive multiplex assay system-platelet antibody bead array","volume":"57","author":"Metzner","year":"2017","journal-title":"Transfusion."},{"key":"2020090103123049000_CIT0007","first-page":"531210","article-title":"Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes","author":"Karczewski","year":"2019","journal-title":"bioRxiv."},{"issue":"6790","key":"2020090103123049000_CIT0008","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/35016636","article-title":"Malaria susceptibility and CD36 mutation","volume":"405","author":"Aitman","year":"2000","journal-title":"Nature."},{"issue":"5","key":"2020090103123049000_CIT0009","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood.V80.5.1105.1105","article-title":"Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine","volume":"80","author":"Greenwalt","year":"1992","journal-title":"Blood."},{"issue":"72","key":"2020090103123049000_CIT0010","doi-asserted-by":"crossref","first-page":"re3","DOI":"10.1126\/scisignal.272re3","article-title":"CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior","volume":"2","author":"Silverstein","year":"2009","journal-title":"Sci Signal."},{"issue":"1","key":"2020090103123049000_CIT0011","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/187152511794182855","article-title":"CD36 as a multiple-ligand signaling receptor in atherothrombosis","volume":"9","author":"Nergiz-Unal","year":"2011","journal-title":"Cardiovasc Hematol Agents Med Chem."},{"issue":"10","key":"2020090103123049000_CIT0012","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1046\/j.1537-2995.1995.351096026370.x","article-title":"Frequency of human platelet antigens among blood donors in northeastern Thailand","volume":"35","author":"Urwijitaroon","year":"1995","journal-title":"Transfusion."},{"issue":"3","key":"2020090103123049000_CIT0013","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI117749","article-title":"Molecular basis of CD36 deficiency. Evidence that a 478C\u2013&gt;T substitution (proline90\u2013&gt;serine) in CD36 cDNA accounts for CD36 deficiency","volume":"95","author":"Kashiwagi","year":"1995","journal-title":"J Clin Invest."},{"issue":"22","key":"2020090103123049000_CIT0014","doi-asserted-by":"crossref","first-page":"9394","DOI":"10.1074\/jbc.M117.781294","article-title":"CD36 receptor regulates malaria-induced immune responses primarily at early blood stage infection contributing to parasitemia control and resistance to mortality","volume":"292","author":"Thylur","year":"2017","journal-title":"J Biol Chem."},{"issue":"2","key":"2020090103123049000_CIT0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/bjh.12014","article-title":"Cytoadherence in paediatric malaria: ABO blood group, CD36, and ICAM1 expression and severe Plasmodium falciparum infection","volume":"159","author":"Cserti-Gazdewich","year":"2012","journal-title":"Br J Haematol."},{"issue":"2","key":"2020090103123049000_CIT0016","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/blood.V83.2.392.392","article-title":"Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes","volume":"83","author":"Yamamoto","year":"1994","journal-title":"Blood."},{"issue":"8","key":"2020090103123049000_CIT0017","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1046\/j.1537-2995.1999.39080873.x","article-title":"CD36 deficiency is frequent and can cause platelet immunization in Africans","volume":"39","author":"Lee","year":"1999","journal-title":"Transfusion."},{"issue":"9","key":"2020090103123049000_CIT0018","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1046\/j.1537-2995.2002.00176.x","article-title":"Isoimmunization against CD36 (glycoprotein IV): description of four cases of neonatal isoimmune thrombocytopenia and brief review of the literature","volume":"42","author":"Curtis","year":"2002","journal-title":"Transfusion."},{"issue":"9","key":"2020090103123049000_CIT0019","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1046\/j.1537-2995.1995.35996029165.x","article-title":"Posttransfusion purpura-like syndrome associated with CD36 (Naka) isoimmunization","volume":"35","author":"Bierling","year":"1995","journal-title":"Transfusion."},{"issue":"3","key":"2020090103123049000_CIT0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1423-0410.1989.tb00826.x","article-title":"A new platelet-specific antigen, Naka, involved in the refractoriness of HLA-matched platelet transfusion","volume":"57","author":"Ikeda","year":"1989","journal-title":"Vox Sang."},{"issue":"1","key":"2020090103123049000_CIT0021","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1423-0410.2001.00048.x","article-title":"Primary refractoriness to platelet transfusion caused by Naka antibody alone","volume":"81","author":"Fujino","year":"2001","journal-title":"Vox Sang."},{"issue":"6","key":"2020090103123049000_CIT0022","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1160\/TH13-05-0435","article-title":"Studies on CD36 deficiency in South China: Two cases demonstrating the clinical impact of anti-CD36 antibodies","volume":"110","author":"Xu","year":"2013","journal-title":"Thromb Haemost."},{"issue":"2","key":"2020090103123049000_CIT0023","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12185-017-2310-5","article-title":"Successful management of a hydropic fetus with severe anemia and thrombocytopenia caused by anti-CD36 antibody","volume":"107","author":"Xu","year":"2018","journal-title":"Int J Hematol."},{"issue":"1","key":"2020090103123049000_CIT0024","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/trf.14369","article-title":"Fetal\/neonatal alloimmune thrombocytopenia due to anti-CD36 antibodies: antibody evaluations by CD36-transfected cell lines","volume":"58","author":"Lin","year":"2018","journal-title":"Transfusion."},{"issue":"4","key":"2020090103123049000_CIT0025","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1423-0410.2008.01095.x","article-title":"Role of anti-Naka antibody, monocytes and platelets in the development of transfusion-related acute lung injury","volume":"95","author":"Nakajima","year":"2008","journal-title":"Vox Sang."}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/labmed\/article-pdf\/51\/5\/540\/33702960\/lmz091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/labmed\/article-pdf\/51\/5\/540\/33702960\/lmz091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T21:02:17Z","timestamp":1695502937000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/51\/5\/540\/5700528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,11]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,1,11]]},"published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmz091","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"value":"0007-5027","type":"print"},{"value":"1943-7730","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2020,1,11]]}}}